trending Market Intelligence /marketintelligence/en/news-insights/trending/hbzx5xk-xkjpu02h2pxh1g2 content esgSubNav
In This List

QRxPharma adds director to board

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


QRxPharma adds director to board

QRxPharma Ltd. appointed Anthony Jefferies to its board.

Jefferies is a partner at Gillis Delaney Lawyers.

Australia's QRxPharma develops pain medications.